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The  increased  frequencies  of the  B  cell  alloantigens  DR2,  DR3,  and  MT1  in 
systemic  lupus  erythematosus  (SLE)  have  suggested  that  genes  influencing  either 
disease susceptibility or expression are located in or near the major human histocom- 
patibility HLA complex on chromosome 6 in man (1-3) and have raised the possibility 
that some immunologic abnormalities that occur in disease could be associated with 
the genetic marker per se rather than be solely a  reflection of the disease process. 
Marked  impairment  of  Fc  receptor-dependent  mononuclear  phagocyte  system 
(MPS)  clearance occurs  in  SLE  (4,  5).  Normals with  the HLA-B8/DR3  phenotype 
may also have delayed MPS clearance  (6).  Since MPS-clearance dysfunction might 
reflect  at  least  in  part  an  intrinsic  cellular  defect,  we  examined  the  Fc  receptor- 
mediated MPS clearance and in vitro monocyte function in disease-free young adults 
with  the  other  HLA  antigens  seen  with  increased  frequency  in  SLE.  Our  results 
indicate that normals with a  haplotype containing either HLA-DR2, -MT1, or -B8/ 
DR3  have impaired MPS clearance compared with their other normal controls. Fc- 
dependent phagocytosis by circulating monocytes was also impaired in the DR2 and 
MT1  groups. 
Materials and Methods 
Subjects.  10  female and  29  male disease-free Caucasian  adults participated in the MPS- 
clearance study after giving written informed consent. 4 female and  13 males were donors for 
in vitro studies. No subject had a family history of SLE or other autoimmune disease sharing 
the HLA associations seen in SLE. Protocols for all studies were approved by the institutional 
Committees on Human Rights in Research. 
Histocompatibility Antigen Determination.  Histocompatibility testing  (HLA)  for serologically 
detectable antigens of the A, B, C, DR, and MT series was performed on isolated mononuclear 
cells and nylon wool-separated B lymphocytes as described (1). 
MPS Fc Receptor-mediated  Clearance Studies.  Fc receptor-mediated MPS studies were done by 
previously described techniques (4, 5). 
Cell  Preparation.  Mononuctear  cells were  separated  by  density centrifugation  on  Ficoli- 
Hypaque  and  purified for aggregate-binding and  rosette-formation assays by adherence  to 
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plastic surfaces (7). 1 ×  10  n peroxidase-positive cells in RPMI 1640 with 20% gammaglobulin- 
free  fetal  calf serum  (FCS)  (Gibco  Laboratories,  Grand  Island, NY)  were  plated  onto  a 
disposable plastic dish (Falcon Labware, Oxnard, CA) that had been precoated overnight with 
heat-inactivated FCS containing  <5/~g/ml of fibronectin. After 60 rain at 37°C in a humidified 
5% CO2 atmosphere, and washes to remove nonadherent cells, disodium EDTA, 0.2% in Hanks' 
balanced salt solution (HBSS), was added and the plates placed at 4°C for 20 rain to remove 
adherent cells. The adherent cells were harvested after gentle action with a rubber policeman, 
washed, counted, and resuspended in HBSS. 
For phagocytosis of IgG-sensitized  erythrocytes, mixed mononuclear  cells obtained by Ficoll- 
Hypaque centrifugation  were stained with peroxidase, and 2.5-5 ×  l0  s peroxidase-positive cells 
were added to each duplicate incubation mixture. The peroxidase-staining characteristics of 
circulating mononuclear cells gradients did not vary according to immunogenetic subgroups 
(DR2 positive: 30 ±  6% [mean ±  SD]; DR2 negative: 34 ±  11%). 
Aggregated-IgG-binding Assay.  IgG model immune complexes, covalently cross-linked with 
bis-diazotized benzidlne, were made in one uniform batch and sized by column chromatogra- 
phy. Sucrose-density  centrifugation  demonstrated predominantly  dimeric complexes with ~ 10% 
larger aggregates. Aliquots were stored at -70°C and iodinated by the iodine monochloride 
technique every 2 wk. Specific activity of the iodinated aggregates ranged from 10 to 42 ×  10  z 
dpm/nmol. IgG molarities were calculated assuming a molecular weight of 160,000 (8). 
Triplicate samples of 3-5 ×  l0  s monocytes in HBSS with 0.2% bovine serum albumin and 
0.1% sodium azide were incubated at 37°C for  1 h with varying concentrations of iodinated 
aggregates both with and without a  large excess of unlabeled aggregates  (~ 100-fold excess). 
Cell-bound and free  aggregates were separated by centrifugation of cells through a  layer of 
phthalate oils (dibutyl phthalate/bis [2-ethylhexyl] phthalate, 1.5:1.0) with a Beckman Micro- 
fuge B (Beckman Instruments, Inc., Palo Alto, CA). Aliquots of the supernatants were removed 
for  gamma counting to determine the concentration of free  aggregate. The microfuge tubes 
were pinched off below the aqueous organic interface and the sedimented cell-bound radioac- 
tivity determined after cutting the tip. 
At least 98% of mononuclear cells labeled with 5aCr passed through the phthalate oils after 
centrifugation. <0.001% of radiolabeled aggregate sedimented in centrifuged cell-free  suspen- 
sions. At least 80% of saturably bound IgG aggregate was displaced by 90-120 rain after further 
incubation with a  large excess of cold aggregate.  Specific  binding, in molecules of IgG per 
monocyte, was calculated after subtraction of nonspecific binding at each ligand concentration 
(8). 
Antibody-sensitized Erythrocyte (EoxA) Rosettes.  Bovine erythrocytes were incubated with rabbit 
IgG anti-bovine erythrocyte antibody (Cappel Laboratories Inc., Cochranville, PA) for 1 h at 
37°C. The amount of antibody used gave maximum rosette formation with peripheral blood 
monocytes; it was a fourfold dilution of the minimal agglutinating titer. 
EoxA Phagocytosis.  EoxA were prepared as above with the addition of 5/~Ci of ~lCr during 
sensitization. Duplicate samples of mixed mononuclear cells for each experimental point were 
combined with varying ratios of EoxA per monocyte, ranging from 5 to 100. The mixture was 
centrifuged at 44 g for 5 rain and incubated at 37°C for 1 h. Noninternalized  EoxA were lysed 
with ammonium chloride solution. After four washes,  the cell pellet was counted in a gamma 
counter to determine mononuclear cell-associated chromium. Overall uptake rates were ex- 
pressed  as  the  mean  number of  erythrocytes  phagocytosed  per  monocyte per  hour  after 
subtraction of an unopsonized Eox control. 
Data Analysis.  MPS-clearance half-time values were determined by nonlinear  regression (9). 
The saturable binding of IgG aggregates was analyzed by Scatchard plots (8). The best fit of 
the experimental points was determined by least squares linear regression.  Phagocytosis of 
EoxA at various erythrocyte/monocyte ratios was assessed by Lineweaver-Burke analysis (10). 
The experimental points were fit by least squares linear regression; the apparent maximum 
velocity  (Vmax)  and  apparent  Miehaelis-Menten constant  (Ks)  were  determined  as  the 
reciprocals of the Y and X intercepts, respectively. 
The MPS-clearance values for the different subject groups were analyzed by the chi-square 
test for homogeneity. The upper 95% confidence limit of the control group in each instance 
defined the upper limit of normal. The Fisher exact test was used to evaluate all 2 ×  2 tables. 
Central tendencies were compared by the Mann-Whitney  U test. Mood's test of dispersion was 
used to compare the distribution of experimental points in the relevant populations (11). 1700  KIMBERLY ET AL.  BRIEF  DEFINITIVE REPORT 
Results 
MPS Fc Receptor-mediated Clearance.  8 normals had the B cell alloantigen DR3 and 
15 were positive for DR2. Two of these subjects were positive for both. Because of the 
association  of  B  cell  alloantigens  DR2  and  DR3  with  SLE  lupus,  the  normal 
population  was  analyzed  for  differences  in  MPS  clearance  in  either  of these  two 
groups. Subjects positive for DR2 were distinguishable from both non-DR2/non-DR3 
normals  (P -- 0.033;  Fisher  exact  test,  one-tailed)  and  all  normals  including  those 
with DR3 (P ~  0.049). Subjects positive for DR3 were not distinguishable from either 
non-DR2/non-DR3  normals  or  all  others  including  DR2.  Division  of the  normal 
group into those positive and negative for either MT1, MT2, or MT3 did not reveal 
any significant differences. 
Previous work by Lawley and associates (6) had suggested that Fc receptor-mediated 
MPS clearance in normal subjects with the HLA-B8/DR3 phenotype was prolonged. 
Accordingly we identified the five subjects in our population with both antigens and 
considered  them  as  a  separate group.  Since  MT1  is  associated  with  DR2,  we  also 
considered  the  possibility that  subjects  who  were  MTl-positive but  DR2-negative 
might share MPS-clearance characteristics more closely resembling DR2 than  their 
non-DR2 colleagues. Accordingly, we divided our normal population into four groups: 
DR2-positive, MTl-positive/DR2-negative, B8/DR3, and other (Fig.  1). Analysis of 
clearance data approached in this way revealed that the DR2-positive group retained 
its difference from the "other" comparison group (P -- 0.037).  In addition  the MT1- 
positive/DR2-negative group and the B8/DR3 group were each distinguishable from 
the  "other" comparison group  (P -- 0.023  and P  ~  0.027,  respectively). In contrast, 
the eight  patients  characterized  by DR3 were not statistically distinguishable  from 
the "other" comparison group (P-- 0.082). 
Fc Receptor Binding.  In vitro data  on  EoxA rosette formation and  IgG aggregate 
binding were obtained on  17  individuals.  Of these only two had  the B8  and  DR3 
antigens. Six subjects were DR2-positive and eight were MTl-positive. No statistically 
distinguishable differences in terms of rosette formation (27.9 +  10.5%  [mean +  SD] 
vs.  24.2  -+ 7.0%)  or maximum binding and association constant  (6.1  +  5.0 vs.  5.9  + 
3.4 X  104/cell;  2.7  +  1.8 vs.  3.3  _+  1.7  ×  108 M -1, respectively) could be determined 
for the DR2 or MT1  individuals when compared to others. 
EoxA Phagocytosis.  Vmax was determined  by Lineweaver-Burke analysis of phag- 
ocytic  rate  determined  at  various  substrate  concentrations  (Table  I).  Vmax  was 
significantly  lower  in  the  DR2  group  when  compared  with  all  others  (P <  0.025, 
Mann-Whitney U  test, one-tailed). Similarly, subjects who were either MTl-positive 
or DR2-positive demonstrated significantly lower Vmax compared with others  (P < 
0.01).  Since the B8/DR3  subgroup and MTl-positive/DR2-negative subgroup con- 
tained only two and three subjects, respectively, their difference compared with others 
could not be tested. 
Discussion 
A  genetic predisposition to autoimmune diseases has been suggested by the associ- 
ation  of various  HLA antigens  with  diseases marked  by altered  immunoreactivity. 
Several  studies  indicate  that  clinically  normal  individuals  with  a  particular  HLA 
antigen  may manifest some differences in immune function usually thought  to be a 
feature of the particular disease associated with that antigen (I 2-15). MPS-clearance 
dysfunction  is  most  consistent  and  most profound  in  SLE  (4,  5).  Lawley et  al.  (6) KIMBERLY ET AL.  BRIEF  DEFINITIVE REPORT  1701 
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Fie.  I.  MPS-clearance  half-times in disease-free individuals by immunogenetic subgroup.  Com- 
pared to upper 95% confidence limit of the control "other" group, HLA-B8/DR3  individuals (P = 
0.027),  MTl-positive/DR2-negative  individuals (P  =  0.023)  and  DR2-positive individuals (P  = 
0.037)  each contain  more  individuals than  expected  with  abnormally long clearance  times. The 
DR2 group  is significantly more dispersed than  both the non-DR2  groups, B8/DR3  and MTI  (P 
<  0.01;  Mood's test of dispersion), and the."other" subgroup (P <  0.04). 
TABLE  [ 
Phagocytosis of Antibody-sensitized Bovine Erythrocytes by HLA-DR2 Subjects 
Lineweaver-Burke analysis*  Phagocytic rate:~ 
HLA-DR 
Vmax  K,n  Slope  t0:1  50:1 
DR2 (n =  6)  2.1 ±  0.7§  6.8 ±  2.9  4.2 ±  3.0  1.4 ±  0.4  1.9 _  0.6 
Non-DR2 (n =  11)  3.9+2.0  9.4:t:5.6  2.7±0.8  2.0±0.7  3.4±1.6 
P  P <  0.025  NSI[  0.05 <  P <  0.10  <0.025  <0.025 
* Determined by least squares linear regression of the double reciprocal representation of phagocytic rate at different 
substrate concentrations. Vmax,  maximum velocity in erythrocytes per monocyte per hour;  Kin, Michaelis-Menten 
constant in erythrocytes per monocyte; slope, slope in h -l. 
:l: Specific phagocytic rates (erythrocytes per monocyte per hour) at two different ratios of erythrocytes to monocytes. 
§ Mean ±  SD. 
recently reported  that  normals with  the  HLA-B8/DR3  phenotype had  delayed  Fc 
receptor-mediated  clearance  of  IgG-sensitized  erythrocytes.  Since  SLE  has  been 
associated with  increased  frequencies of DR2,  DR3,  and  MT1  (1-3),  we sought  to 
evaluate MPS clearance in normal individuals with these specific HLA antigens. 
Our  results  indicate  that  in  young,  healthy  Caucasian  adults,  delayed  MPS 
clearance is evident  in those with either DR2, MT1  (whether DR2+  or DR2-), or 
B8/DR3.  Among our subjects,  DR3  alone  did  not  identify a  group with  impaired 1702  KIMBERLY ET AL.  BRIEF  DEFINITIVE REPORT 
clearance.  The  central  tendencies  or means of these  subgroups were  not  different. 
Analysis of the dispersion in the groups demonstrated that the distribution of values, 
especially in the DR2 individuals, was significantly larger. This finding implies that 
the  DR2  group itself is  heterogeneous with  regard to MPS  clearance  and  that  the 
association of MPS dysfunction with DR2, although perceptible, is not absolute. 
Fries and associates (16)  investigated the saturable binding of monomeric IgGl to 
Fc receptors in B8/DR3  individuals  to see if altered binding might explain  the  Fc 
receptor-mediated clearance defect previously described. Just as with our subgroups, 
no  differences between  HLA-B8/DR3  individuals  and  others  could  be found  with 
regard to Fc receptor binding. 
Using  the  Fc  receptor-dependent  phagocytosis  of EoxA,  we  have  demonstrated 
altered phagocytosis in the DR2  group.  Since rosette formation with an identically 
prepared EoxA was similar, differences in events other than or subsequent to ligand- 
receptor interaction may underlie the decrease in phagocytosis by blood monocytes in 
the DR2 group; the altered MPS clearance, however, depends on 6xed mononuclear 
phagocytes that  might reflect different  properties than  blood monocytes. Since our 
assay  of phagocytosis  involves  a  mixed  mononuclear  cell  preparation,  we  cannot 
exclude the possibility that the difference in phagocytosis rests in the elaboration of 
a  lymphokine-affecting  monocyte  function  rather  than  in  an  intrinsic  monocyte 
defect. 
Intrinsic  MPS  dysfunction  may contribute  significantly  to pathogenesis  in  SLE. 
For example, patients with nephritis  have more pronounced  MPS  defects  (5).  The 
magnitude of MPS  dysfunction is substantially larger in these patients than  in our 
normals  and  has  a  large  dynamic  component,  perhaps  secondary  to  Fc  receptor 
blockade, which changes with clinical status (17).  Individuals with an immunogenet- 
ically determined difference in monocyte function might be more susceptible to such 
an  additional  effect.  Altered  MPS  function  may  also  signify  more  than  altered 
handling of immune complexes and may indicate changes in other monocyte functions 
that involve specific receptor-ligand interactions and phagocytosis either for disposal 
or for further processing and presentation. 
Summary 
Normal individuals with an HLA haplotype containing either DR2, MT1, or B8/ 
DR3 are more likely to have abnormally prolonged Fc receptor-mediated mononu- 
clear  phagocyte  system  (MPS)  clearance  of IgG-sensitized autologous  erythrocytes 
than their normal counterparts without such haplotypes. Although  measurement of 
Fc  receptor  binding  by  rosette  formation  and  saturable  IgG  aggregate  binding 
revealed  no  differences  among groups,  Fc  receptor-mediated  phagocytosis  of IgG- 
sensitized bovine erythrocytes by monocytes was decreased in the DR2-positive and 
MTl-positive individuals.  The basal  in  vivo MPS  clearance  in  normal  individuals 
may be  immunogenetically  determined  and  may reflect  differences  in  phagocytic 
rates. 
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